The purpose of this Research Opportunity Announcement (ROA) is to invite applications from eligible organizations to support the Autism Data Science Initiative (ADSI). ADSI will bring together diverse data resources and community members with lived experience to explore novel contributors and/or to characterize the collective contributions of numerous factors to the causation of autism spectrum disorder (ASD) , hereafter referred to as autism, and their potential role in increasing the prevalence of autism. ADSI will also seek to identify how existing treatments/interventions are used and better understand their outcomes to inform the design of future clinical studies. This initiative will achieve these goals through four strategic aims: 1) to create new integrated data resources, by applying innovative approaches across existing data from research studies or other valid sources, 1 with rigorous privacy protections, for use by the autism research community; 2) to identify and address gaps in available data through targeted data generation; 3) to support the analysis of these integrated data resources that link data on genetic and nongenetic factors (e.g., diagnostic, clinical, behavioral, neurophysiological, pharmaceutical and environmental exposures, complications of pregnancy and peri-natal events) to explore contributors to the causes of autism and/or to identify patterns associated with treatment/intervention outcomes and the use of services for autism; and 4) to provide a venue for replication of these analyses by independent teams to validate findings and increase transparency in the conduct of science.
Research Opportunity Announcement (ROA): OTA-25-006 Autism Data Science initiative
Deadline: June 27, 2025
This ROA will establish the ADSI. Applications from senior/key personnel and groups with the following characteristics are encouraged.
Sponsor Institute/Organizations: National Institutes of Health
Sponsor Type: Government/Federal
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jun 27, 2025
Jun 27, 2025
Varies
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Website URL: https://grants.nih.gov/grants/guide/notice-files/NOT-AA-24-007.html
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.